CA2666339A1 - Biomarkers related to metabolic age and methods using the same - Google Patents

Biomarkers related to metabolic age and methods using the same Download PDF

Info

Publication number
CA2666339A1
CA2666339A1 CA002666339A CA2666339A CA2666339A1 CA 2666339 A1 CA2666339 A1 CA 2666339A1 CA 002666339 A CA002666339 A CA 002666339A CA 2666339 A CA2666339 A CA 2666339A CA 2666339 A1 CA2666339 A1 CA 2666339A1
Authority
CA
Canada
Prior art keywords
metabolite
age
biomarkers
metabolic
level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002666339A
Other languages
English (en)
French (fr)
Inventor
John Ryals
Mike Milburn
Matthew W. Mitchell
Kay A. Lawton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metabolon Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2666339A1 publication Critical patent/CA2666339A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/72—Mass spectrometers
    • G01N30/7233—Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7042—Aging, e.g. cellular aging

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Toxicology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
CA002666339A 2006-10-13 2007-10-12 Biomarkers related to metabolic age and methods using the same Abandoned CA2666339A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85146806P 2006-10-13 2006-10-13
US60/851,468 2006-10-13
PCT/US2007/081268 WO2008063783A2 (en) 2006-10-13 2007-10-12 Biomarkers related to metabolic age and methods using the same

Publications (1)

Publication Number Publication Date
CA2666339A1 true CA2666339A1 (en) 2008-05-29

Family

ID=39430420

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002666339A Abandoned CA2666339A1 (en) 2006-10-13 2007-10-12 Biomarkers related to metabolic age and methods using the same

Country Status (6)

Country Link
US (3) US7781160B2 (enExample)
EP (3) EP2089539B1 (enExample)
JP (1) JP5363984B2 (enExample)
AT (1) ATE536425T1 (enExample)
CA (1) CA2666339A1 (enExample)
WO (1) WO2008063783A2 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2009259540B2 (en) 2008-05-28 2015-11-05 Basf Se Means and methods for assessing liver toxicity
CA2724512A1 (en) * 2008-05-28 2009-12-23 Bennard Van Ravenzwaay Means and methods for assessing liver enzyme induction
KR101068996B1 (ko) 2008-09-18 2011-09-30 한국표준과학연구원 안정동위원소의 질량비를 이용한 동물의 월령 측정 방법
CN102300875B (zh) * 2009-01-28 2014-07-16 财团法人工业技术研究院 肾病相关的生物标记
EP2642293A1 (en) 2012-03-22 2013-09-25 Nestec S.A. 9-oxo-octadecadienoic acid (9-oxo-HODE)as as biomarker for healthy ageing
EP2642296A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. p-Cresol sulphate as biomarker for healthy ageing
EP2642294A1 (en) * 2012-03-22 2013-09-25 Nestec S.A. Phenylacetylglutamine as biomarker for healthy ageing
EP2642295A1 (en) 2012-03-22 2013-09-25 Nestec S.A. 1-O-alkyl-2-acylglycerophosphocholine (PC-O) 40:1 as biomarker for healthy ageing
CL2012001566A1 (es) * 2012-06-11 2013-08-09 Univ De Santiago De Chile Univ Tecnica Federico Santa Maria Metodo analitico para verificar la edad de la carne de animales utilizando perfiles volatiles que comprende introducir una fibra de microextraccion en fase solida en un vial que contiene la carne picada que ha sido calentada, luego desorber en el puerto de inyeccion de un cromatografo de gases, separar los gases y determinar sus concentraciones.
US20160196766A1 (en) * 2013-02-20 2016-07-07 Chistopher Brian Lundin Weight management method
EP3049535B1 (en) * 2013-09-27 2021-12-01 The Regents of the University of California Method to estimate the age of tissues and cell types based on epigenetic markers
AU2015284409B2 (en) 2014-06-30 2020-06-25 The Regents Of The University Of California Ketobutyrate compounds and compositions for treating age-related symptoms and diseases
US9737761B1 (en) * 2014-10-29 2017-08-22 REVVO, Inc. System and method for fitness testing, tracking and training
WO2016124574A1 (en) * 2015-02-03 2016-08-11 Pharnext Diagnostic tools for alzheimer's disease
US10823699B2 (en) 2016-07-29 2020-11-03 Vital Biosciences, Inc. Gel electrophoresis diagnostic kit and methods of using the same
US11353423B2 (en) 2016-12-23 2022-06-07 Vital Biosciences, Inc. Electrophoresis diagnostic methods and kits
WO2018144911A1 (en) 2017-02-02 2018-08-09 Golo Llc Formulations for weight loss and methods of use
CN108956790A (zh) * 2017-05-18 2018-12-07 中国人民解放军第二军医大学第二附属医院 一组氨基酸标志物在急性肾损伤诊断试剂盒中的应用
US12080432B1 (en) 2017-06-01 2024-09-03 The Regents Of The University Of Colorado Plasma metabolome as a predictor of biological aging
CN107273699A (zh) * 2017-07-07 2017-10-20 成都脉安科健生物科技有限公司 营养指导方案获取方法、装置及电子设备
US11484273B2 (en) * 2018-03-06 2022-11-01 International Business Machines Corporation Determining functional age indices based upon sensor data
WO2019208588A1 (en) * 2018-04-24 2019-10-31 Okinawa Institute Of Science And Technology School Corporation Novel trimethyl ammonium metabolites in human blood cells that increase by aging
CN108663448B (zh) * 2018-05-14 2021-07-13 中国医学科学院医药生物技术研究所 一种复方氨基酸注射液中有关物质的检测方法
WO2020252206A1 (en) * 2019-06-12 2020-12-17 Huntington Medical Research Institutes Methods for evaluation and treatment of alzheimer's disease and applications thereof
CN110658286B (zh) * 2019-11-19 2022-07-08 浙江树人学院（浙江树人大学） 利用rp-hplc法同时快速检测苯乳酸和4-羟基苯乳酸含量的方法
CN113125589B (zh) * 2021-03-17 2022-01-04 广东省农业科学院农业质量标准与监测技术研究所 一种代谢组学分析技术鉴定鸭屎香单丛茶的应用
JPWO2022259950A1 (enExample) * 2021-06-10 2022-12-15
CN116798518B (zh) * 2023-06-05 2024-03-08 中南大学湘雅医院 构建代谢物衰老分数及代谢衰老速率的方法及其应用
CN120280160B (zh) * 2025-06-10 2025-09-19 上海交通大学医学院附属仁济医院 代谢衰老的识别模型构建系统、存储介质及试剂盒

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5096787A (en) * 1990-08-03 1992-03-17 Globe-Union Inc. Hydrostatic pump with static resistance for a mobile vehicle battery
JP3350189B2 (ja) * 1993-04-30 2002-11-25 本田技研工業株式会社 電気自動車用バッテリボックス装置
JPH11301077A (ja) 1998-04-23 1999-11-02 Olympus Optical Co Ltd ドットコード評価装置及びドットコード評価方法
JPH11301079A (ja) 1998-04-27 1999-11-02 Canon Inc 印刷方法、印刷システムおよび記録媒体
JPH11301078A (ja) 1998-04-27 1999-11-02 Ricoh Co Ltd 複合装置
US6569624B1 (en) * 1999-08-12 2003-05-27 Wisconsin Alumni Research Foundation Identification of genetic markers of biological age and metabolism
JP2003530130A (ja) * 2000-04-14 2003-10-14 メタボロン インコーポレイテッド メタボロミクスを使用した薬物発見、疾患の処置、及び診断のための方法
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
JP3792547B2 (ja) * 2001-07-19 2006-07-05 株式会社タニタ 生体測定装置
CA2457370A1 (en) * 2001-08-15 2003-02-27 Elixir Pharmaceuticals, Inc. Age-associated markers
RU2004136317A (ru) * 2002-06-14 2006-01-27 Пфайзер Инк. (US) Метаболическое фенотипирование
WO2004085996A2 (en) 2003-03-20 2004-10-07 Albert Einstein College Of Medicine Of Yeshiva University Biomarkers for longevity and disease and uses thereof
CA2527957A1 (en) * 2003-06-02 2005-01-06 Ohio University Use of genes differentially expressed during aging of liver for treatment and diagnosis
JP4255321B2 (ja) 2003-06-25 2009-04-15 本田技研工業株式会社 アシスト搬送方法及びその装置
JP4384896B2 (ja) * 2003-11-14 2009-12-16 フィールファイン株式会社 年齢アセスメントシステム及びプログラム
JP2006134678A (ja) 2004-11-05 2006-05-25 Toyota Central Res & Dev Lab Inc 固体高分子型燃料電池及び燃料電池システム
JP2006134676A (ja) 2004-11-05 2006-05-25 Fuji Electric Fa Components & Systems Co Ltd 加熱温度制御装置
JP2006134677A (ja) 2004-11-05 2006-05-25 Fuji Electric Holdings Co Ltd 固体高分子型燃料電池用セパレータ及びその製造方法

Also Published As

Publication number Publication date
EP2428587A2 (en) 2012-03-14
US20100279337A1 (en) 2010-11-04
ATE536425T1 (de) 2011-12-15
EP2089539A4 (en) 2010-03-17
US7781160B2 (en) 2010-08-24
JP2010507075A (ja) 2010-03-04
JP5363984B2 (ja) 2013-12-11
EP2089539A2 (en) 2009-08-19
WO2008063783A2 (en) 2008-05-29
US20160116461A1 (en) 2016-04-28
WO2008063783A3 (en) 2008-12-24
EP2428587A3 (en) 2012-07-18
US20080124752A1 (en) 2008-05-29
EP2813580A1 (en) 2014-12-17
EP2089539B1 (en) 2011-12-07

Similar Documents

Publication Publication Date Title
US7781160B2 (en) Biomarkers related to metabolic age and methods using the same
JP2010507075A5 (enExample)
EP2546649B1 (en) Biomarkers for fatty liver disease and methods using the same
Wurst et al. Phosphatidylethanol: normalization during detoxification, gender aspects and correlation with other biomarkers and self-reports.
Smits et al. Mitochondrial enzymes discriminate between mitochondrial disorders and chronic fatigue syndrome
BRPI0815095B1 (pt) Método de classificação de um indivíduo de acordo com a tolerância à glicose predita em tolerância à glicose normal (ngt), tolerância à glicose de jejum prejudicada (ifg), ou tolerância à glicose prejudicada (igt), para diabetes tipo 2, método de determinação da suscetibilidade de um indivíduo a diabetes tipo 2 e método de monitoramento da progressão ou regressão do pré- diabetes em um indivíduo
Eng et al. Identification and assessment of markers of biotin status in healthy adults
US20170067884A1 (en) Method for the Early Detection of Autism Spectrum Disorder by use of Metabolic Biomarkers
Kunutsor et al. Serum magnesium and risk of new onset heart failure in men: the Kuopio Ischemic Heart Disease Study
Knottnerus et al. Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots
US20090318369A1 (en) Biomarkers for alzheimer's disease and methods using the same
Cohen et al. ADIPOQ, ADIPOR1, and ADIPOR2 polymorphisms in relation to serum adiponectin levels and BMI in black and white women
CN104956223B (zh) 三甲基胺‑n‑氧化物作为增重和肥胖倾向的生物标志物
CN105026935B (zh) 异戊酰甘氨酸作为增重和肥胖倾向的生物标志物
He et al. A cross–sectional survey of preschool children: Exploring heavy metal exposure, neurotransmitters, and neurobehavioural relationships and mediation effects
Lian et al. Hub genes, a diagnostic model, and immune infiltration based on ferroptosis-linked genes in schizophrenia
Joshi et al. Evidence for perturbed metabolic patterns in bipolar disorder subjects associated with lithium responsiveness
Song et al. Acute effects of ambient nitrogen dioxide exposure on serum biomarkers of nervous system damage in healthy older adults
Li Epidemiological applications of quantitative urinary NMR metabolomics
Hill-Kapturczak et al. Phosphatidylethanol homologs in blood as biomarkers for the time frame and amount of recent alcohol consumption
Stanisławska-Sachadyn et al. Evidence for sex differences in the determinants of homocysteine concentrations
Rushin et al. Metabolic flux analysis of glioblastoma neural stem cells reveals distinctive metabolic phenotypes in ketogenic conditions
McGuckin et al. Hypoxic pregnancy promotes fibrosis and increases stress metabolites in the ovine fetal liver
Guo et al. Analysis of blood metabolite characteristics at birth in preterm infants with bronchopulmonary dysplasia: an observational cohort study
LT et al. Durham, NC 27713 (US)

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20160318